Retina Synthesis

In our latest episode, we discuss the use of inhibitors of IL-6 in the treatment of retinal disease with Dr. Steven M. Yeh, Stanley M. Truhlsen, Jr. , Chair of Ophthalmology a the University of Nebraska.

In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.

In this episode we discuss the results of a phase 2 trial using subcutaneous elamipretide for the treatment of geographic atrophy with Dr. Mark Barakat.

In this episode, we discuss the 3 year results of the Phase 2 trial of the Adverum intravitreal gene therapy with Dr. Dilsher Dhoot, California Retina Consultants, Adjunct Clinical Professor Ophthalmology, Keck School of Medicine of USC.

In this episode we discuss the impressive Phase 4 results of the Belvedere Trial for treatment of neovascular AMD with Dr. Michael Klufas of Wills Eye Hospital.

In our latest episode with the discuss the promising results of a Phase I clinical trial looking at kamuvudine 8 an inflammasome inhibitor in the treatment of geographic atrophy with Dr. Jayakrishna Ambati, Guerry Professor of Ophthalmology at the University of Virginia School of Medicine.

In this episode, we discuss real world treatment of proliferative diabetic retinopathy using data from the Vestrum data base; with Dr. Adrienne Scott, Fred M. Leader Family Retina Professor of the Wilmer Eye Institute and Johns Hopkins University School of Medicine.

In this episode, we discuss the pathbreaking use of an encapsulated cell therapy that produces CNTF for the successful treatment of MacTel with Roger Goldberg, MD, from Walnut Creek, CA.

In our latest update, we discuss strategies for developing a teleretinology network with Dr. Glenn Yiu, Professor of Ophthalmology, University of California, Davis.

In our latest update we discuss the prevention and treatment of endophthalmitis with one of the world's leading authorities, Dr. Harry Flynn , holder of the J. Donald M. Gass Distinguished Chair In Ophthalmology at the Bascom Palmer Eye Institute.